BlackRock’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.2M | Buy |
25,732,990
+7,254,203
| +39% | +$14.1M | ﹤0.01% | 2414 |
|
|
2025
Q1 | $32.5M | Sell |
18,478,787
-62,993
| -0.3% | -$111K | ﹤0.01% | 2605 |
|
|
2024
Q4 | $49.3M | Buy |
18,541,780
+1,567,783
| +9% | +$4.17M | ﹤0.01% | 2428 |
|
|
2024
Q3 | $38.9M | Buy |
16,973,997
+737,233
| +5% | +$1.69M | ﹤0.01% | 2597 |
|
|
2024
Q2 | $47.4M | Buy |
16,236,764
+3,707,716
| +30% | +$10.8M | ﹤0.01% | 2405 |
|
|
2024
Q1 | $45.6M | Sell |
12,529,048
-353,381
| -3% | -$1.29M | ﹤0.01% | 2441 |
|
|
2023
Q4 | $19.5M | Sell |
12,882,429
-325,220
| -2% | -$491K | ﹤0.01% | 2968 |
|
|
2023
Q3 | $17.7M | Sell |
13,207,649
-219,725
| -2% | -$294K | ﹤0.01% | 2956 |
|
|
2023
Q2 | $24.2M | Buy |
13,427,374
+2,229,603
| +20% | +$4.01M | ﹤0.01% | 2856 |
|
|
2023
Q1 | $18.6M | Buy |
11,197,771
+201,036
| +2% | +$334K | ﹤0.01% | 2956 |
|
|
2022
Q4 | $21.1M | Buy |
10,996,735
+709,843
| +7% | +$1.36M | ﹤0.01% | 2955 |
|
|
2022
Q3 | $23M | Buy |
10,286,892
+155,647
| +2% | +$349K | ﹤0.01% | 2913 |
|
|
2022
Q2 | $32.8M | Sell |
10,131,245
-1,120,810
| -10% | -$3.63M | ﹤0.01% | 2741 |
|
|
2022
Q1 | $59.2M | Buy |
11,252,055
+455,021
| +4% | +$2.39M | ﹤0.01% | 2449 |
|
|
2021
Q4 | $91.8M | Buy |
10,797,034
+5,397,329
| +100% | +$45.9M | ﹤0.01% | 2247 |
|
|
2021
Q3 | $53.7M | Buy |
5,399,705
+2,186,242
| +68% | +$21.7M | ﹤0.01% | 2586 |
|
|
2021
Q2 | $29.9M | Buy |
3,213,463
+1,773,029
| +123% | +$16.5M | ﹤0.01% | 3007 |
|
|
2021
Q1 | $15.1M | Buy |
1,440,434
+740,434
| +106% | +$7.74M | ﹤0.01% | 3286 |
|
|
2020
Q4 | $8.19M | Buy |
+700,000
| New | +$8.19M | ﹤0.01% | 3406 |
|